StarZero All shows Try the podcast clipper →

AveXis

2 statements across 1 episodes · 2 bullish · 0 bearish · 2 people on the record · first statement Feb 28, 2019 by Nate Chang · said 9 times in 2 episodes since 2019 · across every show →

Mentions by year

brought up most by Vas Narasimhan (5), Nate Chang (3), Koki Hirasaki (1)

tap a year for its mentions
00511022019episodesmentions
0122019episodes it came up in
002.51522019episodesmentions per episode
2019 9 mentions in 2 episodes 5 per episode

every mention, scene by scene, with the transcript →

Everything said about AveXis, oldest first

Feb 28, 2019 positive
Insight
Chang: Gene therapy modalities create moats providing sustained cash flows
“If you actually think about gene therapy and new technologies, they are creating the moat. Meaning, for example, Avexis and SMA, they are the, probably the leading gene therapy program out there, and they want to continue building that franchise and have not o…”
Nate Chang Feb 28, 2019 ▶ 4:17 What’s with All the Bio M&A in 2019?: A Quick Take
Feb 28, 2019 positive
Assertion Supported
Hirasaki: AveXis acquisition gave Novartis an AAV9 platform for gene delivery
“So the lead asset AXVS- one-on-one it, you know, certainly is going to be probably best in class for SMA, but it also gave Novartis an AAV nine vector platform that it could use to deliver other gene therapies.”
Koki Hirasaki Feb 28, 2019 ▶ 5:36 What’s with All the Bio M&A in 2019?: A Quick Take
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.

Try the podcast clipper Learn more